Ergomed plc Holding(s) in Company (2994C)
June 17 2021 - 10:28AM
UK Regulatory
TIDMERGO TIDMSLA
RNS Number : 2994C
Ergomed plc
17 June 2021
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BN7ZCY67
Issuer Name
ERGOMED PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Aggregate of Standard Life Aberdeen plc affiliated investment
management entities with delegated voting rights on behalf of
multiple managed portfolios
City of registered office (if applicable)
Edinburgh
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s)
subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
16-Jun-2021
6. Date on which Issuer notified
17-Jun-2021
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 10.426520 0.000000 10.426520 5,087,170
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 10.26 0.00 10.26
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BN7ZCY67 5,087,170 10.426520
====================== ====================== ====================== ======================
Sub Total 8.A 5,087,170 10.426520
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
Standard Life
Aberdeen plc
======================= ===================== ===================== ======================
Standard Life Standard Life
Aberdeen plc Investments
(Holdings) Limited
======================= ===================== ===================== ======================
Standard Life Standard Life
Aberdeen plc Investments Limited 10.089525 10.089525
======================= ===================== ===================== ======================
Standard Life Aberdeen plc
=============================================== ===================== ===================== ======================
Standard Life Aberdeen Asset
Aberdeen plc Management PLC
======================= ===================== ===================== ======================
Standard Life Aberdeen Asset
Aberdeen plc Managers Limited
======================= ===================== ===================== ======================
Standard Life Aberdeen plc
=============================================== ===================== ===================== ======================
Standard Life Standard Life
Aberdeen plc Investments
(Holdings) Limited
======================= ===================== ===================== ======================
Standard Life Aberdeen Standard
Aberdeen plc Capital Limited
======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
In reference to section 9, the shares detailed are managed by
the named discretionary investment management entity within
multiple portfolios on behalf of underlying clients, based on
investment management agreements whereby the client has delegated
the exercise of the voting power to the referenced investment
manager.
This disclosure reflects the fact that the voting rights
effectively held indirectly by the underlying intermediate holding
company Standard Life Investments (Holdings) Limited ("SLIHL") and
held by the underlying investment management entity Standard Life
Investments Limited ("SLIL") increased above the 10% notifiable
thresholds due to trading on 16 June 2021. SLIHL now effectively
holds 10.108229% and SLIL now holds 10.089525% of the delegated
voting rights of the shares in Ergomed plc.
12. Date of Completion
17-June-2021
13. Place Of Completion
Edinburgh, United Kingdom
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLDKOBBPBKDAAD
(END) Dow Jones Newswires
June 17, 2021 11:28 ET (15:28 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2023 to Apr 2024